metoclopramide has been researched along with Hyaline Membrane Disease in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sankaran, K | 1 |
| Yeboah, E | 1 |
| Bingham, WT | 1 |
| Ninan, A | 1 |
1 other study available for metoclopramide and Hyaline Membrane Disease
| Article | Year |
|---|---|
Use of metoclopramide in preterm infants.
Topics: Gastric Emptying; Gestational Age; Humans; Hyaline Membrane Disease; Infant; Infant, Newborn; Infant | 1982 |